126 related articles for article (PubMed ID: 9089759)
1. Effects of lentinan on abnormal ingestive behaviors induced by tumor necrosis factor.
Tamura R; Tanebe K; Kawanishi C; Torii K; Ono T
Physiol Behav; 1997 Mar; 61(3):399-410. PubMed ID: 9089759
[TBL] [Abstract][Full Text] [Related]
2. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.
Sheppard BC; Venzon D; Fraker DL; Langstein HN; Jensen JC; Norton JA
Cancer Res; 1990 Jul; 50(13):3928-33. PubMed ID: 2354441
[TBL] [Abstract][Full Text] [Related]
3. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.
Stovroff MC; Fraker DL; Swedenborg JA; Norton JA
Cancer Res; 1988 Aug; 48(16):4567-72. PubMed ID: 3165053
[TBL] [Abstract][Full Text] [Related]
4. Cachectic effects of recombinant human tumor necrosis factor in rats.
Darling G; Fraker DL; Jensen JC; Gorschboth CM; Norton JA
Cancer Res; 1990 Jul; 50(13):4008-13. PubMed ID: 2354450
[TBL] [Abstract][Full Text] [Related]
5. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
Mahony SM; Beck SA; Tisdale MJ
Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
[TBL] [Abstract][Full Text] [Related]
6. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.
Grunfeld C; Wilking H; Neese R; Gavin LA; Moser AH; Gulli R; Serio MK; Feingold KR
Cancer Res; 1989 May; 49(10):2554-60. PubMed ID: 2713842
[TBL] [Abstract][Full Text] [Related]
7. The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia.
Langstein HN; Doherty GM; Fraker DL; Buresh CM; Norton JA
Cancer Res; 1991 May; 51(9):2302-6. PubMed ID: 1901758
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization and antiviral activity of lentinan from Lentinus edodes mycelia against infectious hematopoietic necrosis virus.
Ren G; Xu L; Lu T; Yin J
Int J Biol Macromol; 2018 Aug; 115():1202-1210. PubMed ID: 29704603
[TBL] [Abstract][Full Text] [Related]
9. Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats.
Llovera M; López-Soriano FJ; Argilés JM
J Natl Cancer Inst; 1993 Aug; 85(16):1334-9. PubMed ID: 8340946
[TBL] [Abstract][Full Text] [Related]
10. Synergism between IL-1 beta and TNF-alpha on the activity of the pituitary-adrenal axis and on food intake of rats.
Van der Meer MJ; Sweep CG; Pesman GJ; Borm GF; Hermus AR
Am J Physiol; 1995 Apr; 268(4 Pt 1):E551-7. PubMed ID: 7733251
[TBL] [Abstract][Full Text] [Related]
11. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
Tracey KJ; Wei H; Manogue KR; Fong Y; Hesse DG; Nguyen HT; Kuo GC; Beutler B; Cotran RS; Cerami A
J Exp Med; 1988 Mar; 167(3):1211-27. PubMed ID: 3351436
[TBL] [Abstract][Full Text] [Related]
12. Cachectin activity in the serum of cachectic, tumor-bearing rats.
Stovroff MC; Fraker DL; Norton JA
Arch Surg; 1989 Jan; 124(1):94-9. PubMed ID: 2910253
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
Tracey KJ; Morgello S; Koplin B; Fahey TJ; Fox J; Aledo A; Manogue KR; Cerami A
J Clin Invest; 1990 Dec; 86(6):2014-24. PubMed ID: 2254457
[TBL] [Abstract][Full Text] [Related]
14. Meal patterns in response to the intracerebroventricular administration of interleukin-1 beta in rats.
Plata-Salamán CR
Physiol Behav; 1994 Apr; 55(4):727-33. PubMed ID: 8190802
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.
Steffen BT; Lees SJ; Booth FW
J Appl Physiol (1985); 2008 Dec; 105(6):1950-8. PubMed ID: 18801959
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of prostaglandin synthesis do not improve food intake or body weight of tumor-bearing rats.
McCarthy DO
Res Nurs Health; 1999 Oct; 22(5):380-7. PubMed ID: 10520190
[TBL] [Abstract][Full Text] [Related]
17. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
[TBL] [Abstract][Full Text] [Related]
18. Reversal of weight loss induced by tumour necrosis factor-alpha.
Mahony SM; Tisdale MJ
Cancer Lett; 1989 Jun; 45(3):167-72. PubMed ID: 2731160
[TBL] [Abstract][Full Text] [Related]
19. Prevention of adjuvant-induced cachexia in rats by cyclosporin A.
Rofe AM; Whitehouse MW; Bourgeois CS; Haynes DR; Vernon-Roberts B
Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():63-9. PubMed ID: 2318512
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tumor necrosis factor-alpha chronically administered in rats: lack of cachectic effect.
Mullen BJ; Harris RB; Patton JS; Martin RJ
Proc Soc Exp Biol Med; 1990 Apr; 193(4):318-25. PubMed ID: 2320602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
